Asone of the oldest proverbs from Aristotle's book, also referringto C. majus original Greek name, "one swallow does notmake a spring," even if we observe a lot of "first swallows,"we urgently need more, to ensure rational exploitation ofthe huge potential hidden in the inconspicuous and commonweed.AUTHOR CONTRIBUTIONSSZ: Wrote phytochemical and bioactivity parts of the manuscriptand critically reviewed and corrected the final manuscript;AJ-D: Wrote the ethno botanical and historical section of themanuscript; MW-K and IS: Contributed to the phytochemicaland analytical parts of the manuscript; AJ: Contributed tothe antimicrobial activity section of the manuscript; AM:Developed the entire concept of this review, wrote bioactivity andpharmacology sections, and critically read and corrected all partsof the paper.FUNDINGThe scientific activity of Botanical Garden of Medicinal Plantsis supported by the Ministry of Science and Higher Educationof Poland, grant No. 215259/E-394/SPUB/2-16/1. AM and SZget support from the Wroclaw Medical University grant No.ST.D030.17.028.ACKNOWLEDGMENTSAssistance in graphical abstract preparation by Miss HannaZielinska is kindly acknowledged. The support of WroclawMedical University is acknowledged.SUPPLEMENTARY MATERIALThe Supplementary Material for this article can be foundonline at: https://www.frontiersin.org/articles/10.3389/fphar.2018.00299/full#supplementary-materialSupplementary Figure 1 | Chelidonium majus has been highly valued by ancientphysicians. Nowadays, it is still attracting researchers' and clinicians' attention forits unique composition of the yellow latex, rich in alkaloids and proteins.Supplementary Table 1 | The examples of conditions used to isolate alkaloidsfrom C. majus.Supplementary Table 2 | The examples of application the separation techniquesin analysis of alkaloids from C. majus.REFERENCESAbdel-Aziz, H., Kelber, O., Lorkowski, G., and Storr, M. (2017). Evaluatingthe multitarget effects of combinations through multistep clustering ofpharmacological data: the example of the commercial preparation iberogast.Planta Med. 83, 1130-1140. doi: 10.1055/s-0043-116852Agrawal, A. A., and Konno, K. (2009). Latex: a model for understandingmechanisms, ecology, and evolution of plant defence against herbivory. Annu.Rev. Ecol. Evol. Syst. 40, 311-331. doi: 10.1146/annurev.ecolsys.110308.120307Arora, D., and Sharma, A. (2013). A review on phytochemical andpharmacological potential of genus Chelidonium. Pharmacogn. J. 5, 184-190.doi: 10.1016/j.phcgj.2013.07.006Barton, B. H., and Castle, T. (1845). The British Flora Medica, or History of theMedicinal Plants of Great Britain. London: E. Cox.Basu, P., Bhowmik, D., and Suresh Kumar, G. (2013). The benzophenanthridinealkaloid chelerythrine binds to DNA by intercalation: photophysical aspectsand thermodynamic results of iminium versus alkanolamine interaction.J. Photoch. Photobiol. B, Biol. 129, 57-68. doi: 10.1016/j.jphotobiol.2013.09.011Bauhin, J. (1651). Historia Plantarum Uniuersalis: Noua et Absolutissima CumConsensu et Dissensu Circa eas. 3, Vol. 483. Ebrodunum.Benchabane, M., Schluter, U., Vorster, J., Goulet, M. C., and Michaud, D. (2010).Plant cystatins. Biochimie 92, 1657-1666. doi: 10.1016/j.biochi.2010.06.006Best, M. R., and Brightman, F. H. (1999). The Book of Secrets of Albertus Magnus.York Beach, ME: Weiser Books.Biswas, S. J. (2013).Chelidoniummajus: a review on pharmacological activities andclinical effects. Global J. Res. Med. Plants Indigen. Med. 2, 238-245.Boegge, S. C., Kesper, S., Verspohl, E. J., and Nahrstedt, A. (1996). Reduction ofACh-induced contraction of rat isolated ileum by coptisine, (+)-caffeoylmalicacid,Chelidoniummajus, andCorydalis lutea extracts. PlantaMed. 62, 173-174.doi: 10.1055/s-2006-957845Bogucka-Kocka, A., and Zalewski, D. (2017). Qualitative and quantitativedetermination of main alkaloids of Chelidonium majus L. using thin-layerchromatographic--densitometric method. Acta Chromatogr. 29, 385-397.doi: 10.1556/1326.2017.29.3.09Borghini, A., Pietra, D., di Trapani, C., Madau, P., Lubinu, G., and Bianucci, A.M. (2015). Data mining as a predictive model for Chelidonium majus extractsproduction. Ind. Crops Prod. 64, 25-32. doi: 10.1016/j.indcrop.2014.10.066Frontiers in Pharmacology | www.frontiersin.org April 2018 | Volume 9 | Article 299187Zielin'ska et al. Medicinal Uses of Chelidonium majusBozeman, E. N., Srivatsan, S., Mohammadi, H., Daniels, D., Shashidharamurthy,R., and Selvaraj, P. (2012). Ukrain R(c), a plant derived semi-syntheticcompound, exerts antitumor effects against murine and human breastcancer and induce protective antitumor immunity in mice. Exp. Oncol. 34,340-347.Bugatti, C., Colombo, M. L., and Tome, F. (1987). High-performance liquidchromatographic separation of quaternary alkaloids of Chelidonium majusL. Roots. J. Chromatogr. A, 393, 312-316. doi: 10.1016/S0021-9673(01)94228-1Cahlikova, L., Opletal, L., Kurfurst, M., Macakova, K., Kulhankova, A.,and Hostalkova, A. (2010). Acetylcholinesterase and butyrylcholinesteraseinhibitory compounds from Chelidonium majus (Papaveraceae). Nat. Prod.Commun. 5, 1751-1754.Capistrano, I. R., Wouters, A., Lardon, F., Gravekamp, C., Apers, S.,and Pieters, L. (2015). In vitro and in vivo investigations on theantitumour activity of Chelidonium majus. Phytomedicine 22, 1279-1287.doi: 10.1016/j.phymed.2015.10.013Cho, K. M., Yoo, I. D., and Kim,W. G. (2006). 8-hydroxydihydrochelerythrine and8-hydroxydihydrosanguinarine with a potent acetylcholinesterase inhibitoryactivity from Chelidonium majus L. Biol. Pharm. Bull. 29, 2317-2320.doi: 10.1248/bpb.29.2317Ciric', A., Vinterhalter, B., Savikin-Fodulovic', K., Sokovic', M., and Vinterhalter,D. (2008). Chemical analysis and antimicrobial activity of methanol extractsof celandine (Chelidonium majus L.) plants growing in nature and cultured invitro. Arch. Biol. Sci. 60, 7-8. doi: 10.2298/ABS0801169CColombo, M. L., and Bosisio, E. (1996). Pharmacological activities of Chelidoniummajus L. (Papaveraceae). Pharmacol. Res. 33, 127-134.Cordes, N., Plasswilm, L., Bamberg, M., and Rodemann, H. P. (2002).Ukrain R(c) , an alkaloid thiophosphoric acid derivative of Chelidonium majusL. protects human fibroblasts but not human tumour cells in vitro againstionizing radiation. Int. J. Radiat. Biol. 78, 17-27. doi: 10.1080/09553000110089991Cordes, N., Blaese, M. A., Plasswilm, L., Rodemann, H. P., and Van Beuningen, D.(2003). Fibronectin and laminin increase resistance to ionizing radiation andthe cytotoxic drug Ukrain R(c) in human tumour and normal cells in vitro. Int. J.Radiat. Biol. 79, 709-720. doi: 10.1080/09553000310001610240Czekan'ski, M. (2007). Ziola s'w. Hildegardy. Lecznicze Wlas'ciwos'ci ziol wedlugopisu s'w. Krakow: Hildegardy z Bingen. Wydawnictwo M.De Verdmon, L. J. (1936). "Jaskolcze ziele," in Kuracja roslinna (Warszawa:Wydawnictwo M. Arcta), 267-268.Deljanin, M., Nikolic, M., Baskic, D., Todorovic, D., Djurdjevic, P., Zaric, M., et al.(2016). Chelidonium majus crude extract inhibits migration and induces cellcycle arrest and apoptosis in tumor cell lines. J. Ethnopharmacol. 190, 362-371.doi: 10.1016/j.jep.2016.06.056Deng, A. J., Zhang, Z. H., Li, Q., Ma, L., and Qin, H. L. (2016). Two new hopane-type triterpenes from the aerial part of Chelidoniummajus. Phytochem. Lett. 17,75-78. doi: 10.1016/j.phytol.2016.07.009Dickenson, P. B., and Fairbairn, J. W. (1975). The ultrastructure of the alkaloidalvesicles of Papaver somniferum latex. Ann. Bot. 39, 707-712.El-Readi, M. Z., Eid, S., Ashour, M. L., Tahrani, A., and Wink, M. (2013).Modulation of multidrug resistance in cancer cells by chelidonineand Chelidonium majus alkaloids. Phytomedicine 20, 282-294.doi: 10.1016/j.phymed.2012.11.005Ernst, E., and Schmidt, K. (2005). Ukrain R(c) - a new cancer cure? Asystematic review of randomised clinical trials. BCM Cancer 5:69.doi: 10.1186/1471-2407-5-69Etxenagusia, M. A., Anda, M., Gonzalez-Mahave, I., Fernandez, E., and Fernandezde Corres, L. (2000). Contact dermatitis from Chelidonium majus (greatercelandine). Contact Derm. 43:47.European Medicines Agency (2011). Assessment Report on Chelidonium majus L.,Herba. London.Farrugia, D., and Slevin, M. L. (2000). Alternative cancer cures. Lancet Oncol, 1,204-205. doi: 10.1016/S1470-2045(00)00147-9Farrugia, D., and Slevin, M. L. (2001). Clinical testing of Ukrain R(c) - Authors' reply.Lancet Oncol. 2:10. doi: 10.1016/S1470-2045(00)00189-3Fulde, G., andWichtl, M. (1994). Analytic von Schollkraut.Deutsch Apoth Ztg. 134,1031-1035.Funel, N., Costa, F., Pettinari, L., Taddeo, A., Sala, A., Chiriva-Internati, M., et al.(2010). Ukrain affects pancreas cancer cell phenotype in vitro by targetingMMP-9 and Intra-/Extracellular SPARC expression. Pancreatology 10, 545-552.doi: 10.1159/000266127Gagliano, N., Moscheni, C., Torri, C., Magnani, I., Bertelli, A. A., Nowicky,W., et al. (2006). Effect of Ukrain on matrix metalloproteinase-2 andSecreted Protein Acidic and Rich in Cysteine (SPARC) expressionin human glioblastoma cells. Anti Cancer Drugs 17, 189-194.doi: 10.1097/00001813-200602000-00010Gagliano, N., Moscheni, C., Torri, C., Donetti, E., Magnani, I., Costa, F., et al.(2007). Ukrain modulates glial fibrillary acidic protein, but not connexin 43expression, and induces apoptosis in human cultured glioblastoma cells. AntiCancer Drugs 18, 669-676. doi: 10.1097/CAD.0b013e32808bf9ecGagliano, N., Pettinari, L., Aureli, M., Martinelli, C., Colombo, E., Costa,F., et al. (2011). Malignant phenotype of renal cell carcinoma cells isswitched by Ukrain administration in vitro. Anti Cancer Drugs 22, 749-762.doi: 10.1097/CAD.0b013e328346c7f7Gagliano, N., Volpari, T., Clerici, M., Pettinari, L., Barajon, I., Portinaro, N.,et al. (2012). Pancreatic cancer cells retain the epithelial-related phenotype andmodify mitotic spindle microtubules after the administration of ukrain in vitro.Anti Cancer Drugs 23, 935-946. doi: 10.1097/CAD.0b013e32835507bcGanan, N. A., Dias, A. M. A., Bombaldi, F., Zygadlo, J. A., Brignole, E.A., De Sousa, H. C., et al. (2016). Alkaloids from Chelidonium majus L.:fractionated supercritical CO2 extraction with co-solvents. Sep. Purif. Technol.165, 199-207. doi: 10.1016/j.seppur.2016.04.006Gebhardt, R. (2009). Prevention of cadmium-induced toxicity in liver-derived cellsby the combination preparation Hepeel R(c). Environ. Toxicol. Pharmacol. 27,402-409. doi: 10.1016/j.etap.2009.01.006GerencVer, M., Turecek, P. L., Kistner, O., Mitterer, A., Savidis-Dacho, H., andBarrett, N. P. (2006). In vitro and in vivo anti-retroviral activity of the substancepurified from the aqueous extract of Chelidonium majus L. Antivir. Res. 72,153-156. doi: 10.1016/j.antiviral.2006.03.008Gilca, M., Gaman, L., Panait, E., Stoian, I., and Atanasiu, V. (2010). Chelidoniummajus-an integrative review: traditional knowledge versus modern findings.Forschende Komplementarmedizin. 17, 241-248. doi: 10.1159/000321397Grosso, C., Ferreres, F., Gil-Izquierdo, A., Valentao, P., Sampaio, M., Lima,J., et al. (2014). Box-Behnken factorial design to obtain a phenolic-richextract from the aerial parts of Chelidonium majus L. Talanta 130, 128-136.doi: 10.1016/j.talanta.2014.06.043Gu, Y., Qian, D., Duan, J. A.,Wang, Z., Guo, J., Tang, Y., et al. (2010). Simultaneousdetermination of seven main alkaloids of Chelidonium majus L. by ultra-performance LC with photodiode-array detection. J. Sep. Sci. 33, 1004-1009.doi: 10.1002/jssc.200900690Habermehl, D., Kammerer, B., Handrick, R., Eldh, T., Gruber, C., Cordes, N., et al.(2006). Proapoptotic activity of Ukrain R(c) is based on Chelidonium majus L.alkaloids and mediated via a mitochondrial death pathway.